About Angela
Angela is well known as a leading expert in commercial and regulatory matters in the healthcare, medical device, aged care and community services sectors. She has over 20 years of experience advising health, aged care, medical device and not-for-profit providers throughout Australia.
Angela has advised on a number of high profile matters including assisting clients to respond to the Royal Commission into Aged Care; advising on registration of goods under Australia’s Therapeutic Goods Register; acquisitions in the residential aged care industry; corporate governance issues, regulatory matters, investigations, privacy, contracting and risk management.
Angela has a strong reputation for policy development, and training in privacy, capacity and consent, medication compliance and management. Angela is a regular contributor to publications including The future of aged care governance.
Angela is currently a committee member of the Northern Sydney Local Health District Human Research Ethics Committee (HREC). Before practising law, Angela had experience in the health and community services sector as a practising psychologist.
Experience
-
Therapeutic Goods
Acting for global suppliers of therapeutic goods on complex regulatory requirements including the registration under the Australian Register of Therapeutic Goods.
-
Medical Devices
Adviser to global leaders in med-tech devices in relation to their agreements, partnerships, advertising and supply chain management, including regulatory and compliance risk management.
-
Royal Commission
Adviser to clients in response to the Royal Commission into the Aged Care sector including notices to produce, preparing submissions and witness statements and appearing at hearings.
-
Aged Care
Advising market leading aged care providers on the acquisitions and sales of portfolios of residential aged care facilities and retirement villages across multiple sites.
-
Regulation
Advising operators in the health and aged care sector in responding to regulatory action, including legislative changes, not mets and serious risk, notices of noncompliance and sanctions.